Global Brain Tumor Therapeutics Market Research Report 2023

Report ID: 1917635 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Brain Tumor Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Surgery
        1.2.3 Radiation Therapy
        1.2.4 Targeted Therapy
        1.2.5 Chemotherapy
        1.2.6 Immunotherapy
    1.3 Market by Application
        1.3.1 Global Brain Tumor Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Oncology Treatment Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Brain Tumor Therapeutics Market Perspective (2017-2028)
    2.2 Brain Tumor Therapeutics Growth Trends by Region
        2.2.1 Brain Tumor Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Brain Tumor Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Brain Tumor Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Brain Tumor Therapeutics Market Dynamics
        2.3.1 Brain Tumor Therapeutics Industry Trends
        2.3.2 Brain Tumor Therapeutics Market Drivers
        2.3.3 Brain Tumor Therapeutics Market Challenges
        2.3.4 Brain Tumor Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Brain Tumor Therapeutics Players by Revenue
        3.1.1 Global Top Brain Tumor Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Brain Tumor Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Brain Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Brain Tumor Therapeutics Revenue
    3.4 Global Brain Tumor Therapeutics Market Concentration Ratio
        3.4.1 Global Brain Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Therapeutics Revenue in 2021
    3.5 Brain Tumor Therapeutics Key Players Head office and Area Served
    3.6 Key Players Brain Tumor Therapeutics Product Solution and Service
    3.7 Date of Enter into Brain Tumor Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Tumor Therapeutics Breakdown Data by Type
    4.1 Global Brain Tumor Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Brain Tumor Therapeutics Forecasted Market Size by Type (2023-2028)
5 Brain Tumor Therapeutics Breakdown Data by Application
    5.1 Global Brain Tumor Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Brain Tumor Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Brain Tumor Therapeutics Market Size (2017-2028)
    6.2 North America Brain Tumor Therapeutics Market Size by Country (2017-2022)
    6.3 North America Brain Tumor Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Brain Tumor Therapeutics Market Size (2017-2028)
    7.2 Europe Brain Tumor Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Brain Tumor Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Brain Tumor Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Brain Tumor Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Brain Tumor Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Brain Tumor Therapeutics Market Size (2017-2028)
    9.2 Latin America Brain Tumor Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Brain Tumor Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Brain Tumor Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Brain Tumor Therapeutics Introduction
        11.1.4 Pfizer Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Brain Tumor Therapeutics Introduction
        11.2.4 Novartis Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Brain Tumor Therapeutics Introduction
        11.3.4 Roche Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Brain Tumor Therapeutics Introduction
        11.4.4 Merck Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Detail
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Brain Tumor Therapeutics Introduction
        11.5.4 AstraZeneca Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.5.5 AstraZeneca Recent Development
    11.6 GE Healthcare
        11.6.1 GE Healthcare Company Detail
        11.6.2 GE Healthcare Business Overview
        11.6.3 GE Healthcare Brain Tumor Therapeutics Introduction
        11.6.4 GE Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.6.5 GE Healthcare Recent Development
    11.7 Hitachi Medical
        11.7.1 Hitachi Medical Company Detail
        11.7.2 Hitachi Medical Business Overview
        11.7.3 Hitachi Medical Brain Tumor Therapeutics Introduction
        11.7.4 Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.7.5 Hitachi Medical Recent Development
    11.8 Philips Healthcare
        11.8.1 Philips Healthcare Company Detail
        11.8.2 Philips Healthcare Business Overview
        11.8.3 Philips Healthcare Brain Tumor Therapeutics Introduction
        11.8.4 Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.8.5 Philips Healthcare Recent Development
    11.9 Novocure
        11.9.1 Novocure Company Detail
        11.9.2 Novocure Business Overview
        11.9.3 Novocure Brain Tumor Therapeutics Introduction
        11.9.4 Novocure Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.9.5 Novocure Recent Development
    11.10 DelMar Pharmaceuticals
        11.10.1 DelMar Pharmaceuticals Company Detail
        11.10.2 DelMar Pharmaceuticals Business Overview
        11.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Introduction
        11.10.4 DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2017-2022)
        11.10.5 DelMar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Brain Tumor Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Surgery
    Table 3. Key Players of Radiation Therapy
    Table 4. Key Players of Targeted Therapy
    Table 5. Key Players of Chemotherapy
    Table 6. Key Players of Immunotherapy
    Table 7. Global Brain Tumor Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Brain Tumor Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Brain Tumor Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Brain Tumor Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Brain Tumor Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Brain Tumor Therapeutics Market Share by Region (2023-2028)
    Table 13. Brain Tumor Therapeutics Market Trends
    Table 14. Brain Tumor Therapeutics Market Drivers
    Table 15. Brain Tumor Therapeutics Market Challenges
    Table 16. Brain Tumor Therapeutics Market Restraints
    Table 17. Global Brain Tumor Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Brain Tumor Therapeutics Market Share by Players (2017-2022)
    Table 19. Global Top Brain Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Therapeutics as of 2021)
    Table 20. Ranking of Global Top Brain Tumor Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Brain Tumor Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Brain Tumor Therapeutics Product Solution and Service
    Table 24. Date of Enter into Brain Tumor Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Brain Tumor Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Brain Tumor Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Brain Tumor Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Brain Tumor Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Brain Tumor Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Brain Tumor Therapeutics Revenue Market Share by Application (2017-2022)
    Table 32. Global Brain Tumor Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Brain Tumor Therapeutics Revenue Market Share by Application (2023-2028)
    Table 34. North America Brain Tumor Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Brain Tumor Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Brain Tumor Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Brain Tumor Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Brain Tumor Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Brain Tumor Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Pfizer Company Detail
    Table 45. Pfizer Business Overview
    Table 46. Pfizer Brain Tumor Therapeutics Product
    Table 47. Pfizer Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 48. Pfizer Recent Development
    Table 49. Novartis Company Detail
    Table 50. Novartis Business Overview
    Table 51. Novartis Brain Tumor Therapeutics Product
    Table 52. Novartis Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 53. Novartis Recent Development
    Table 54. Roche Company Detail
    Table 55. Roche Business Overview
    Table 56. Roche Brain Tumor Therapeutics Product
    Table 57. Roche Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 58. Roche Recent Development
    Table 59. Merck Company Detail
    Table 60. Merck Business Overview
    Table 61. Merck Brain Tumor Therapeutics Product
    Table 62. Merck Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 63. Merck Recent Development
    Table 64. AstraZeneca Company Detail
    Table 65. AstraZeneca Business Overview
    Table 66. AstraZeneca Brain Tumor Therapeutics Product
    Table 67. AstraZeneca Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 68. AstraZeneca Recent Development
    Table 69. GE Healthcare Company Detail
    Table 70. GE Healthcare Business Overview
    Table 71. GE Healthcare Brain Tumor Therapeutics Product
    Table 72. GE Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 73. GE Healthcare Recent Development
    Table 74. Hitachi Medical Company Detail
    Table 75. Hitachi Medical Business Overview
    Table 76. Hitachi Medical Brain Tumor Therapeutics Product
    Table 77. Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 78. Hitachi Medical Recent Development
    Table 79. Philips Healthcare Company Detail
    Table 80. Philips Healthcare Business Overview
    Table 81. Philips Healthcare Brain Tumor Therapeutics Product
    Table 82. Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 83. Philips Healthcare Recent Development
    Table 84. Novocure Company Detail
    Table 85. Novocure Business Overview
    Table 86. Novocure Brain Tumor Therapeutics Product
    Table 87. Novocure Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 88. Novocure Recent Development
    Table 89. DelMar Pharmaceuticals Company Detail
    Table 90. DelMar Pharmaceuticals Business Overview
    Table 91. DelMar Pharmaceuticals Brain Tumor Therapeutics Product
    Table 92. DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 93. DelMar Pharmaceuticals Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Brain Tumor Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Surgery Features
    Figure 3. Radiation Therapy Features
    Figure 4. Targeted Therapy Features
    Figure 5. Chemotherapy Features
    Figure 6. Immunotherapy Features
    Figure 7. Global Brain Tumor Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Oncology Treatment Centers Case Studies
    Figure 10. Others Case Studies
    Figure 11. Brain Tumor Therapeutics Report Years Considered
    Figure 12. Global Brain Tumor Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Brain Tumor Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Brain Tumor Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Brain Tumor Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Brain Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Brain Tumor Therapeutics Revenue in 2021
    Figure 18. North America Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Brain Tumor Therapeutics Market Share by Country (2017-2028)
    Figure 20. United States Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Brain Tumor Therapeutics Market Share by Country (2017-2028)
    Figure 24. Germany Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Brain Tumor Therapeutics Market Share by Region (2017-2028)
    Figure 32. China Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Brain Tumor Therapeutics Market Share by Country (2017-2028)
    Figure 40. Mexico Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Brain Tumor Therapeutics Market Share by Country (2017-2028)
    Figure 44. Turkey Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Brain Tumor Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Pfizer Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 48. Roche Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 50. AstraZeneca Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 51. GE Healthcare Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 52. Hitachi Medical Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 53. Philips Healthcare Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 54. Novocure Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 55. DelMar Pharmaceuticals Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals
Frequently Asked Questions
Brain Tumor Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Brain Tumor Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Brain Tumor Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Braze Alloys

Brazing is a process which joins two or more metals by melting them and flowing another metal in  ... Read More

Linings

Linings are insulating and protective layers applied inside a tank, pipeline and/or furnace.� ... Read More